Brief: Parabilis Medicines Reports Second Quarter 2026 Financial Results And Provides Business Updates
13/08/2026 12:24
BRIEF-Parabilis Medicines Reports Second Quarter 2026 Financial Results And Provides Business Updates Aug 13 (Reuters) - Parabilis Medicines Inc PBLS.O:
PARABILIS MEDICINES REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
PARABILIS MEDICINES - ENDS Q2 WITH $1.10 BILLION CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES; EXPECTED TO FUND OPERATIONS INTO 2030
PARABILIS MEDICINES: ON TRACK TO INITIATE DESMOID TUMOR PHASE 3 TRIAL IN H1 2027
Source text: ID:nGNX7n33
Further company coverage: PBLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Parabilis Medicines
See all newsBrief: Parabilis Medicines Initiates Dose-Ranging Clinical Study Of Zolucatetide In Familial Adenomatous Polyposis
Brief: Parabilis Medicines Reports Second Quarter 2026 Financial Results And Provides Business Updates
Brief: Alphabet Reports Share Stake In SpaceX, Fervo Energy And Parabilis Medicines
U.S. RESEARCH ROUNDUP-East West Bancorp, First Citizens Bancshares, UMB Financial